ReviewAmerican journal of hypertension2017
Air Pollution and Cardiometabolic Disease: An Update and Call for Clinical Trials.
Review in American journal of hypertension, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04908917 (Reducing AIR Pollution Exposure to Lower Blood PRESSURE), which is not on this map. Cited by 77 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Reducing AIR Pollution Exposure to Lower Blood PRESSURE
Who cites it
77 citing papers in PubMed, 1 synthesis or guideline pooled it.
- WHO Environmental Noise Guidelines for the European Region: A Systematic Review on Environmental Noise and Cardiovascular and Metabolic Effects: A Summary.International journal of environmental research and public health · 2018Pooled it
- Prenatal Household Air Pollution Exposure and Childhood Blood Pressure in Rural Ghana.Environmental health perspectives · 2024Trial
- Short-term differences in cardiac function following controlled exposure to cookstove air pollution: The subclinical tests on volunteers exposed to smoke (STOVES) study.Environment international · 2021Trial
- Acute Blood Pressure and Cardiovascular Effects of Near-Roadway Exposures With and Without N95 Respirators.American journal of hypertension · 2019Trial
- Review
- Article
- Atmospheric stressors and kidney diseases.Nature reviews. Nephrology · 2026Review
- Disaster-Related Medical Geology Research: A Bibliometric Mapping of Geogenic Exposure Pathways and Earth-Health Integration (1980-2025).GeoHealth · 2026Article
- PMEnvironment & health (Washington, D.C.) · 2026Article
- Polygenic risk and air pollution trends in relation to type 2 diabetes: evidence from the Taiwan Biobank.Diabetology & metabolic syndrome · 2026Article
- Association between Personal Exposure to Household Air Pollution and Glycated Hemoglobin among Women in Rural Areas of Guatemala, India, Peru, and Rwanda: Household Air Pollution Intervention Network Trial.Journal of health & pollution · 2025Article
- Lifetime air pollution exposure from prenatal to 18 years and cardiovascular health in young adulthood: findings from a UK birth cohort.Environment international · 2025Article
- Modeling Daily Plume Specific Smoke Concentrations for Health Effects Studies with Estimates of Fire Size, Plume Age, and Fuel Type.ACS ES&T air · 2025Article
- Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) to tackle central nervous system diseases: role as a promising approach.European journal of medical research · 2025Review
- Long-Term Exposure to Ambient Air Pollution and Metabolic Syndrome and Its Components.Journal of obesity & metabolic syndrome · 2025Review
- Cardiovascular Emergency Hospitalization Risks of PMEnvironment & health (Washington, D.C.) · 2025Article
- Effects of engineered nanomaterials on the cardiovascular system.Journal of occupational health · 2025Review
- AI4HealthyCities: a protocol for a mixed-method ethnographic study on the social determinants of cardiovascular health in New York City.BMJ public health · 2025Article
- Cardiovascular health and economic outcomes under improved air quality in China: a modelling study.BMJ global health · 2024Article
- Impact of air pollution and noise exposure on cardiovascular disease incidence and mortality: A systematic review.Heliyon · 2024Review
17 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Fine particulate matter <2.5 µm (PM2.5) air pollution is a leading cause of global morbidity and mortality. The largest portion of deaths is now known to be due to cardiovascular disorders. Several air pollutants can trigger acute events (e.g., myocardial infarctions, strokes, heart failure). However, mounting evidence additionally supports that longer-term exposures pose a greater magnified risk to cardiovascular health. One explanation may be that PM2.5 has proven capable of promoting the development of chronic cardiometabolic conditions including atherosclerosis, hypertension, and diabetes mellitus. Here, we provide an updated overview of recent major studies regarding the impact of PM2.5 on cardiometabolic health and outline key remaining scientific questions. We discuss the relevance of emerging trials evaluating personal-level strategies (e.g., facemasks) to prevent the harmful effects of PM2.5, and close with a call for large-scale outcome trials to allow for the promulgation of formal evidence-base recommendations regarding their appropriate usage in the global battle against air pollution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.